Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma

27 Jan 2021

Abstract excerpt

PURPOSE We sought to investigate clinical outcomes of relapsed medulloblastoma and to compare molecular features between patient-matched diagnostic and relapsed tumors. METHODS Children and infants enrolled on either SJMB03 (NCT00085202) or SJYC07 (NCT00602667) trials who experienced medulloblastoma relapse were analyzed for clinical outcomes, including anatomic and temporal patterns of relapse and postrelapse...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Metastases and Treatment
Share to Glioma Diagnosis and Treatment
Share to Neuroblastoma Research and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33502920
DOI: 10.1200/jco.20.01359

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed MedulloblastomaPMID 33502920Read ↗

Emergence and maintenance of actionable genetic drivers at medulloblastoma relapse.Semantic proximity Read ↗

Medulloblastoma in the Molecular EraSemantic proximity Read ↗

Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis.Semantic proximity Read ↗

Adaptive Convergence of Methylomes Reveals Epigenetic Drivers and Boosters of Repeated Relapses in Patient-matched Childhood Ependymomas and Identifies Targets for Anti-Recurrence TherapiesSemantic proximity Read ↗

Comparison of transcriptome profiles between medulloblastoma primary and recurrent tumors uncovers novel variance effects in relapses.Semantic proximity Read ↗

Relapse patterns and outcome after relapse in standard risk medulloblastoma: a report from the HIT-SIOP-PNET4 study.Semantic proximity Read ↗

Drivers Underlying Metastasis and Relapse in Medulloblastoma and Targeting StrategiesSemantic proximity Read ↗

Medulloblastoma in the age of molecular subgroups: a reviewSemantic proximity Read ↗

Preventing recurrence in Sonic Hedgehog Subgroup Medulloblastoma using OLIG2 inhibitor CT-179Semantic proximity Read ↗

Clinically applicable 39 genes targeted mutational analysis predicts recurrence in pediatric medulloblastoma: a monocenter cohort studySemantic proximity Read ↗

Molecular markers and potential therapeutic targets in non-WNT/non-SHH (group 3 and group 4) medulloblastomasSemantic proximity Read ↗

Epigenetic Alterations of Repeated Relapses in Patient-matched Childhood EpendymomasSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.